西奈山伊坎医学院 孙小奇助理教授 6月26日下午学术报告

发布时间:2024-06-24访问量:56设置

报告人:孙小奇 助理教授西奈山伊坎医学院)

报告题目From Nature to Nano: Bioinspired Intelligent Delivery Systems

报告时间:2024626日 下午2:00

报告地点:909-B

 

报告摘要:

Nature is our most profound teacher. By mimicking biological mechanisms, we can devise intelligent nano delivery systems. In this presentation, I will begin by discussing how to leverage the body's inherent transportation systems, such as red blood cells and high-density lipoproteins, for the efficient delivery of drugs and vaccines. Additionally, I will explore the critical role of nutritional metal ions in immune regulation and demonstrate how these ions can be utilized to modulate immune responses. Using bioinspired metal ion-coordinated lipid nanoparticles, we can not only enhance the delivery of STING agonists but also fine-tune intracellular signaling pathways for superior therapeutic outcomes. Lastly, I will discuss how certain physiological mechanisms can be harnessed to maximize the efficacy of lipid nanoparticles for tissue/cell-specific delivery and in vivo CRISPR gene editing. Overall, bioinspired intelligent delivery systems hold great promise for addressing the current challenges of drug and gene delivery.

 

个人简介 :

A person wearing glasses and a black shirt with mountains in the background  Description automatically generated

 

Dr. Xiaoqi Sun is an incoming Assistant Professor in the Department of Immunology and Immunotherapy, the Icahn Genomics Institute (IGI) and the Lipschultz Precision Immunology Institute at Icahn School of Medicine at Mount Sinai. He is currently a Scientist and Delivery Team Leader at Editas Medicine. Before that, he obtained his PhD in Pharmaceutical Sciences from the University of Michigan in 2021 (Advisor: James Moon) and MS in Chemistry from Soochow University in 2016 (Advisor: Zhuang Liu). His research interests focus on interdisciplinary studies across CRISPR gene editing, immune engineering and cell therapy for treatment of severe diseases.  He has published 31 peer-reviewed papers and filed 24 patent applications, which laid the foundation of 2 startup companies and 1 drug candidate tested in Phase I clinical trial. His research has been recognized by multiple prestigious awards, including the CRS PhD Thesis Award and the Rackham Pre-doctoral Fellowship.

 

联系人:冯良珠 教授


返回原图
/